Y.A. Abuodeh - Concepedia

Author

Y.A. Abuodeh

Moffitt Cancer Center ORCID

Also Known As

Y Abuodeh, Y. Abuodeh, Y.A. Abuodeh, Yazan A. Abuodeh, Yazan Abuodeh, Yazan Asad Abuodeh

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Moffitt Cancer Center University of South Florida

About

Y.A. Abuodeh is an author at Moffitt Cancer Center specializing in radiation oncology, medicine, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	563
2	Health Sciences	6	6	435
3	Hepatology	2	2	181
4	Head And Neck Surgery	1	1	95
5	Metabolism	1	1	20

Y.A. Abuodeh

Publications

821

Citations

H-Index

Page 1

	Year	Citations
Radiosensitivity Differences Between Liver Metastases Based on Primary Histology Suggest Implications for Clinical Outcomes After Stereotactic Body Radiation Therapy Kamran A. Ahmed, Jimmy J. Caudell, Ghassan El‐Haddad, International Journal of Radiation OncologyBiologyPhysics Adaptive RadiotherapyRadiation MedicineHepatologyRadiation TherapyMedicine	2016	161
Clinical outcomes of melanoma brain metastases treated with stereotactic radiosurgery and anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitor, or conventional chemotherapy Kamran A. Ahmed, Y.A. Abuodeh, Michelle Echevarria, Annals of Oncology Neuro-oncologySurgical OncologyRadiation TherapyMelanoma Brain MetastasesMedicine	2016	135
Treatment delays, race, and outcomes in head and neck cancer A.O. Naghavi, Michelle Echevarria, Tobin J. Strom, Cancer Epidemiology OncologyCancer ManagementHead And Neck CancerHead And Neck SurgeryHead And Neck Squamous Cell Carcinoma	2016	95
Fractionated stereotactic radiotherapy to the post-operative cavity for radioresistant and radiosensitive brain metastases Kamran A. Ahmed, J. Freilich, Y.A. Abuodeh, Journal of Neuro-Oncology Adaptive RadiotherapyNeuro-oncologyRadiation TherapyRadiosensitive Brain MetastasesRadionuclide Therapy	2014	83
Having Medicaid insurance negatively impacts outcomes in patients with head and neck malignancies A.O. Naghavi, Michelle Echevarria, G. Daniel Grass, Cancer	2016	83
The role of dose escalation and proton therapy in perioperative or definitive treatment of chondrosarcoma and chordoma: An analysis of the National Cancer Data Base Russell F. Palm, Daniel Oliver, G.Q. Yang, Cancer	2019	79
Patient choice for high‐volume center radiation impacts head and neck cancer outcome A.O. Naghavi, Michelle Echevarria, Tobin J. Strom, Cancer Medicine	2018	40
Using the Albumin-Bilirubin (ALBI) grade as a prognostic marker for radioembolization of hepatocellular carcinoma Homan Mohammadi, Y.A. Abuodeh, William Jin, Journal of Gastrointestinal Oncology	2018	36
Dose escalated neoadjuvant chemoradiotherapy with dose-painting intensity-modulated radiation therapy and improved pathologic complete response in locally advanced esophageal cancer Puja Venkat, Ravi Shridhar, A.O. Naghavi, Diseases of the Esophagus Advanced Esophageal CancerSurgical OncologyNeoadjuvant ChemoradiotherapyEsophageal CancerRadiation Therapy	2017	21
Prognostic value of pre-treatment F-18-FDG PET-CT in patients with hepatocellular carcinoma undergoing radioembolization Y.A. Abuodeh, A.O. Naghavi, Kamran A. Ahmed, World Journal of Gastroenterology	2016	20

Page 1